Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Publication year range
1.
Environ Pollut ; 346: 123654, 2024 Apr 01.
Article in English | MEDLINE | ID: mdl-38402933

ABSTRACT

The seafloor is recognised as a major sink for marine litter. However, studies conducted in this compartment addressing marine litter densities and its interactions with fauna are scarce, mainly due to sampling constraints. In this paper, we assess marine litter density, composition and interactions with marine communities and evaluate its relationship with fishing activities at the "Banco de la Concepción" seamount (Canary Islands, Spain). We took advantage of underwater video records taken with a Remotely Operated Towed Vehicle in the framework of the LIFE IP INTEMARES project. A total of 56 video transects were analysed covering about 9 km with 19 h of video recording. Transects were categorised as high, low, and null fishing effort based on the Vessel Monitoring System (VMS) positional data registered between 2009 and 2017. Litter items were recorded in 70% of the transects with a mean density of 2122 (±2464) items km-2. There were significant differences in litter densities over the three levels of fishing pressure, with a density decrease from stations of high to stations of null fishing pressure. Regarding categories, plastic was by far the most abundant category found (83.1%), mainly consisting of fishing lines, both monofilaments and entangled longlines. The study of the interactions of marine litter with fauna showed that less than 20% of the items presented an interaction with benthic organisms either by causing or not a visible impact. The sponge Asconema setubalense accounted for more than half (57.4%) of all interactions, but only 5% of all A. setubalense specimens showed physical damage.


Subject(s)
Environmental Monitoring , Plastics , Spain , Plastics/analysis , Waste Products/analysis , Video Recording
3.
Genet Couns ; 25(3): 289-97, 2014.
Article in English | MEDLINE | ID: mdl-25365851

ABSTRACT

The 9p trisomy is a relatively frequent disorder, while pure 9p trisomies are less frequent and usually derived from 9;22 translocations, duplications or 9p extra chromosomes. Here we report a patient with pure trisomy 9p derived from a terminal balanced unreciprocal translocation. The patient derived to the genetic service by psychomotor delay, presented at 2 years and 11 months: short stature, open anterior fontanelle, dysplastic ears, facial dysmorphisms, long and broad first toes with hypoplastic nails, central nervous system and skeletal alterations. The patient karyotype was: 46,XY,der(10)t(9;10) (p13.1;qter)mat while the mother karyotype was: 46,XX,t(9;10)(p13.1;qter). The presence of the subtelomeric region of 10q showed by FISH as well as the duplication of 9p subtelomere was further confirmed with multiplex ligation dependent probe amplification (MLPA) for the subtelomeric region of all chromosomes. The mechanism of formation seems to be due to a telomere break in 10q leading to loss of telomeric functions, permitting the 9p fusion; this has been supported with molecular probes showing telomere shortening in interstitial telomeric repeats, which are unable to prevent chromosome fusion. This is one of the few cases reported with terminal translocations (not jumping) preserving the subtelomeric region and highlights the importance of subtelomeric probes in terminal arrangements, and the utility of molecular probes, such as MLPA in defining this kind of abnormalities. In the clinical context, the patient presented a high proportion of 9p trisomy features which is expected considering the large 9p segment involved and the presence of the critical region 9p22.


Subject(s)
Abnormalities, Multiple/diagnosis , Abnormalities, Multiple/genetics , Chromosomes, Human, Pair 22/genetics , Chromosomes, Human, Pair 9/genetics , Craniofacial Abnormalities/genetics , Developmental Disabilities/genetics , Translocation, Genetic/genetics , Trisomy/diagnosis , Trisomy/genetics , Child, Preschool , Chromosome Duplication/genetics , Craniofacial Abnormalities/diagnosis , Developmental Disabilities/diagnosis , Humans , In Situ Hybridization, Fluorescence , Karyotyping , Male , Syndrome , Telomere/genetics
4.
Aliment Pharmacol Ther ; 30(10): 1039-48, 2009 Nov 15.
Article in English | MEDLINE | ID: mdl-19709097

ABSTRACT

BACKGROUND: Few studies have examined the incidence of uncomplicated peptic ulcer or the trends in factors affecting its incidence. AIM: To estimate the incidence rate of uncomplicated peptic ulcer in the UK from 1997 to 2005 and report temporal changes in the main known preventive and risk factors. METHODS: Population-based cohort study of 1 049 689 patients enrolled in The Health Improvement Network in the UK. We estimated the incidence rate of uncomplicated peptic ulcer and evaluated temporal trends in demographic characteristics and prescription patterns for various anti-inflammatory and gastroprotective agents. RESULTS: Overall uncomplicated peptic ulcer incidence was 0.75 cases per 1000 persons-years, declining from 1.1 to 0.52 cases per 1000 person-years between 1997 and 2005. Distributions of age, gender and alcohol habits were similar in 1997 and 2005. The proportion of documented Helicobacter pylori-negative cases increased from 5% to 12%. Monthly prevalence of subjects with prescriptions for traditional non-aspirin NSAIDs changed from 7.7% to 6.8%, Coxibs from 0% to 0.7%, and proton pump inhibitors (PPIs) from 2.4% to 7.4%. The proportion of subjects on prescription NSAIDs on PPIs increased continuously over time. CONCLUSION: A reduction in H. pylori-related peptic ulcers, changing patterns in NSAID use and increasing PPI use may have contributed to a decline in uncomplicated peptic ulcer incidence in the UK.


Subject(s)
Drug Prescriptions/statistics & numerical data , Peptic Ulcer/epidemiology , Adult , Age Factors , Aged , Aged, 80 and over , Female , Humans , Incidence , Male , Middle Aged , Overweight , Peptic Ulcer/diagnosis , Peptic Ulcer/prevention & control , Risk Factors , Sex Factors , Smoking/trends , United Kingdom/epidemiology
5.
J Epidemiol Community Health ; 63(4): 332-6, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19240084

ABSTRACT

BACKGROUND: To estimate the incidence and prevalence of type 1 and type 2 diabetes in the UK general population from 1996 to 2005. METHODS: Using the Health Improvement Network database, patients with type 1 or type 2 diabetes were identified who were 10-79 years old between 1996 and 2005. Prevalent cases (n = 49 999) were separated from incident cases (n = 42 642; type 1 = 1256, type 2 = 41 386). Data were collected on treatment patterns in incident cases, and on body mass index in prevalent and incident cases. RESULTS: Diabetes prevalence increased from 2.8% in 1996 to 4.3% in 2005. The incidence of diabetes in the UK increased from 2.71 (2.58-2.85)/1000 person-years in 1996 to 4.42 (4.32-4.53)/1000 person-years in 2005. The incidence of type 1 diabetes remained relatively constant throughout the study period; however, the incidence of type 2 diabetes increased from 2.60 (2.47-2.74)/1000 person-years in 1996 to 4.31 (4.21-4.42)/1000 person-years in 2005. Between 1996 and 2005, the proportion of individuals newly diagnosed with type 2 diabetes who were obese increased from 46% to 56%. Treatment with metformin increased across the study period, while treatment with sulphonylureas decreased. CONCLUSIONS: The prevalence and incidence of type 2 diabetes have increased in the UK over the past decade. This might be primarily explained by the changes in obesity prevalence. Also, there was a change in drug treatment pattern from sulphonylureas to metformin.


Subject(s)
Diabetes Mellitus, Type 1/epidemiology , Diabetes Mellitus, Type 2/epidemiology , Adolescent , Adult , Age Distribution , Aged , Child , Diabetes Mellitus, Type 1/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Epidemiologic Methods , Female , Forecasting , Humans , Hypoglycemic Agents/therapeutic use , Male , Middle Aged , Sex Distribution , United Kingdom/epidemiology , Young Adult
6.
Aliment Pharmacol Ther ; 28(5): 629-37, 2008 Sep 01.
Article in English | MEDLINE | ID: mdl-18616644

ABSTRACT

BACKGROUND: Between 3% and 40% of patients surviving an episode of upper gastrointestinal bleeding (UGIB) experience a recurrence within 1 year. Aim To characterize further the recurrence rate of UGIB and to investigate the role of long-term acid suppressive therapy in its secondary prevention. METHODS: Recurrent cases of UGIB were identified among patients registered in The Health Improvement Network in the UK. A nested case-control analysis provided relative risk (RR) estimates of factors associated with recurrence. RESULTS: Of 1287 patients included, 67 (5.2%) were identified with a recurrent UGIB episode, corresponding to a recurrence rate of 17.5 per 1000 person-years during a mean follow-up of 3 years. The greatest risk of recurrence was in patients prescribed the oral anticoagulant warfarin (RR: 5.38; 95% confidence interval: 2.02-14.36). Use of a single proton pump inhibitor (PPIs) was associated with a reduced risk of recurrence (RR: 0.51; 95% confidence interval: 0.26-0.99), even in patients taking warfarin, while current use of H(2)-receptor antagonists was not. After the first episode of UGIB, use of nonsteroidal anti-inflammatory drugs and aspirin was greatly reduced, preventing estimation of the risk associated with these drugs. CONCLUSION: Long-term PPI therapy reduces the risk of UGIB recurrence.


Subject(s)
Anti-Ulcer Agents/therapeutic use , Duodenal Ulcer/prevention & control , Gastrointestinal Hemorrhage/prevention & control , Proton Pump Inhibitors/therapeutic use , Stomach Ulcer/prevention & control , Adult , Aged , Aged, 80 and over , Anti-Inflammatory Agents, Non-Steroidal/adverse effects , Aspirin/adverse effects , Case-Control Studies , Duodenal Ulcer/chemically induced , Female , Gastrointestinal Hemorrhage/chemically induced , Humans , Male , Middle Aged , Prospective Studies , Risk Factors , Secondary Prevention , Stomach Ulcer/chemically induced , Treatment Outcome , Warfarin/adverse effects
7.
Acta Ginecol (Madr) ; 26: 267-72, 1975 Mar.
Article in Spanish | MEDLINE | ID: mdl-12258778

ABSTRACT

PIP: On the basis of available data, the most likely action of IUDs is that of an endometrial polymorphonuclear infiltration, affecting both the upward movement of spermatozoa and the series of steps that precede implantation, although other actions may play a subsidiary role to a greater or lesser extent. With respect to IUDs of the Cu-T type, it appears that basically they act through metabolic endometrial changes initiated by actions affecting enzyme systems, which prevent the endometrium from becoming receptive to nidation. It is also highly probable that they have a harmful effect on the spermatozoa moving through the uterine cavity, and it is possible that cervical mucus, under the action of Cu-T IUDs, may alter its function as sperm filter, rendering sperm penetration more difficult, although the latter action is still being researched. Blastocysts appear to remain unaffected by all the actions of Cu-T IUDs.^ieng


Subject(s)
Cervix Uteri , Contraception , Embryo Implantation , Endometrium , Enzymes , Intrauterine Devices, Copper , Biology , Family Planning Services , Genitalia , Genitalia, Female , Intrauterine Devices , Physiology , Urogenital System , Uterus
SELECTION OF CITATIONS
SEARCH DETAIL
...